Activity against carcinoma and method for the treatment of carcinoma
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 16, 1991
Grant Date -
N/A
app pub date -
Nov 21, 1988
filing date -
Nov 21, 1988
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The use of L-ascorbic acid, or a pharmaceutically acceptable salt thereof, in combination with 5,6-O-benzylidene-L-ascorbic acid, or 5,6-O-benzylidene-L-ascorbic acid deuterated at least at the 1-position of the aldehyde group of the benzylidene moiety, or a pharmaceutically acceptable salt of such acids, results in a synergistically enhanced cytotoxicity on human carcinoma cells.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully